Rep. Lisa C. McClain Purchases Shares of Dolby Laboratories (NYSE:DLB)

Key Points

• Representative Lisa C. McClain purchased shares of Dolby Laboratories (NYSE:DLB) valued between $1,001 and $15,000 on June 24th.
• Dolby reported quarterly earnings exceeding analysts' expectations, with $0.78 earnings per share and revenue of $315.55 million, marking a 9.2% increase year-over-year.
• The company announced a quarterly dividend of $0.33 per share, resulting in an annualized dividend yield of 1.8%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Dolby Laboratories NYSE: DLB. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Dolby Laboratories stock on June 24th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded down $0.5650 during mid-day trading on Thursday, reaching $72.8350. The stock had a trading volume of 399,473 shares, compared to its average volume of 404,577. Dolby Laboratories has a fifty-two week low of $68.24 and a fifty-two week high of $89.66. The stock's 50-day simple moving average is $74.29 and its 200-day simple moving average is $76.72. The firm has a market capitalization of $6.98 billion, a PE ratio of 26.68 and a beta of 0.91.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. During the same quarter last year, the firm posted $0.71 earnings per share. The company's revenue for the quarter was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio (DPR) is 48.35%.

Hedge Funds Weigh In On Dolby Laboratories

Several hedge funds have recently made changes to their positions in DLB. Alpine Bank Wealth Management purchased a new position in shares of Dolby Laboratories in the first quarter valued at $25,000. Cheviot Value Management LLC purchased a new position in Dolby Laboratories during the first quarter worth about $27,000. MAI Capital Management grew its position in Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after buying an additional 162 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories during the first quarter worth about $29,000. Finally, Allworth Financial LP grew its position in Dolby Laboratories by 590.4% during the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker's stock worth $37,000 after buying an additional 431 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Kevin J. Yeaman sold 39,875 shares of the business's stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark Andrew Sherman sold 15,000 shares of the business's stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $75.02, for a total value of $1,125,300.00. Following the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at approximately $4,681,022.94. The trade was a 19.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 141,049 shares of company stock valued at $10,521,141. 38.39% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Rosenblatt Securities restated a "buy" rating and issued a $95.00 target price on shares of Dolby Laboratories in a report on Friday, August 1st. Barrington Research restated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Friday, May 2nd. Wall Street Zen lowered Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Tigress Financial raised their target price on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Dolby Laboratories has a consensus rating of "Buy" and an average price target of $103.00.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.